FDA Approves Combo Pill for Alzheimer’s Disease: The FDA has approved a combination pill for moderate to severe Alzheimer's disease in people already being treated with both drugs.
The pill, called Namzaric, combines memantine hydrochloride extended-release (Namenda) and donepezil hydrochloride (Aricept).
The two drugs are often prescribed together. About 70% of people on Namenda XR are also on Aricept, says David Nicholson, PhD, in a statement. He's the senior vice president of global brands R&D for drugmaker Actavis.
No comments:
Post a Comment